Cargando…
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis
BACKGROUND/AIMS: Irsogladine maleate, an enhancer of gastric mucosal protective factors, has demonstrated its efficacy for various gastric mucosal injuries. The aim of this study was to evaluate the efficacy and safety of irsogladine for prevention of nonsteroidal anti-inflammatory drugs (NSAIDs) or...
Autores principales: | Shim, Ki-Nam, Kim, Jin Il, Kim, Nayoung, Kim, Sang Gyun, Jo, Yun Ju, Hong, Su Jin, Shin, Jeong Eun, Kim, Gwang Ha, Park, Kyung Sik, Choi, Suck Chei, Kwon, Joong Goo, Kim, Jie-Hyun, Kim, Hyun Jin, Kim, Ji Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718769/ https://www.ncbi.nlm.nih.gov/pubmed/29847892 http://dx.doi.org/10.3904/kjim.2017.370 |
Ejemplares similares
-
Gastroprotective effects of irsogladine maleate on ethanol/hydrochloric acid induced gastric ulcers in mice
por: Kwon, Seong Chun, et al.
Publicado: (2021) -
Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin
por: Song, Hyun Jin, et al.
Publicado: (2013) -
Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori
por: Seo, Jae Hyun, et al.
Publicado: (2016) -
Suppressive Effect of Irsogladine Maleate on Diethylnitrosamine‐initiated and Phenobarbital‐promoted Hepatocarcinogenesis in Male F344 Rats
por: Sugie, Shigeyuki, et al.
Publicado: (1998) -
Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice
por: Onuma, Wakana, et al.
Publicado: (2016)